A method for coupling cytomegalovirus antigens to aldehyde-fixed erythrocytes for use in passive hemagglutination
- PMID: 6315750
- DOI: 10.1016/0166-0934(83)90002-2
A method for coupling cytomegalovirus antigens to aldehyde-fixed erythrocytes for use in passive hemagglutination
Abstract
A method for coupling cytomegalovirus (CMV) antigens to aldehyde-fixed erythrocytes for use in a passive hemagglutination assay for antibody to CMV is described. This method uses acid buffer instead of tannic acid for coupling CMV-complement fixation (CF) antigen to the stabilized cells. The coated cells are stable for at least 6 mth at -70 degrees C and for 5 days at 4 degrees C. This provides an inexpensive reagent having a sensitivity for anti-CMV detection which compares favorably with that of the CF test and enzyme immunoassay.
Similar articles
-
Freeze-dried erythrocytes for an indirect hemagglutination test for detection of cytomegalovirus antibodies.J Clin Microbiol. 1981 Jun;13(6):1026-30. doi: 10.1128/jcm.13.6.1026-1030.1981. J Clin Microbiol. 1981. PMID: 6265494 Free PMC article.
-
Passive hemagglutination for cytomegalovirus antibody: specificity and stability of reagents.J Virol Methods. 1986 May;13(2):143-8. doi: 10.1016/0166-0934(86)90082-0. J Virol Methods. 1986. PMID: 3016015
-
A method for coupling the hepatitis B surface antigen to aldehyde-fixed erythrocytes for use in passive hemagglutination.J Virol Methods. 1981 Apr;2(5):269-75. doi: 10.1016/0166-0934(81)90025-2. J Virol Methods. 1981. PMID: 6785288 No abstract available.
-
Improved indirect hemagglutination test for cytomegalovirus using human O erythrocytes in lysine.J Clin Microbiol. 1979 Jul;10(1):64-8. doi: 10.1128/jcm.10.1.64-68.1979. J Clin Microbiol. 1979. PMID: 227921 Free PMC article.
-
Assessment of human cytomegalovirus antibody detection techniques.Arch Virol. 1980;64(4):287-301. doi: 10.1007/BF01320614. Arch Virol. 1980. PMID: 6249241 Review. No abstract available.
Cited by
-
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients.Haematologica. 2011 Jun;96(6):896-904. doi: 10.3324/haematol.2011.040386. Epub 2011 Mar 21. Haematologica. 2011. PMID: 21422117 Free PMC article. Clinical Trial.
-
Confirmation of human cytomegalovirus by reverse passive hemagglutination with monoclonal antibodies reactive to the major glycosylated peptide (GP-66).J Clin Microbiol. 1986 Sep;24(3):474-7. doi: 10.1128/jcm.24.3.474-477.1986. J Clin Microbiol. 1986. PMID: 2428828 Free PMC article.
-
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients.Oncologist. 2012;17(3):436-45. doi: 10.1634/theoncologist.2011-0342. Epub 2012 Feb 21. Oncologist. 2012. PMID: 22357731 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources